Stay updated with breaking news from Immuron Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Globally integrated biopharmaceutical company Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has initiated the second cohort of a clinical trial aimed at assessing the...
ASX Futures are pointing to a strong slide in early trading today, with the ASX likely to fall 83 points or 1.2%, following tumbling US and European markets...
Australia’s benchmark index ended the session down 1.5% as local investors followed Wall Street's lead overnight on worries about rising Middle East...
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steven Lydeamore will be presenting at the 16th annual LD Micro Main Event on Wednesday, October 4th at 11:00 PT at...
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steve Lydeamore speaks with Proactive following news the company has achieved record monthly sales of its...